Advancing scientific discovery to improve quality of life
- November 20, 2020
- Susan Murphy
Accomplishing scientific breakthroughs can be a slow and arduous process. However, time is of the essence when dementia, cancer, cardiac disease, COVID-19, and more continue to upend lives around the world. This makes our corporate mission—to empower researchers to fast-track scientific discoveries—significantly important. Our technology is helping pave the way for advanced disease detection, drug discovery, and therapeutic development, crucial for improving human health and wellness.

From Silicon Valley to laboratories worldwide
Our company began its journey in 1983 when Stanford University researchers founded Molecular Devices to develop tools that study cellular response. We introduced our first microplate reader in 1987. Today, 160,000 of Molecular Devices’ leading-edge platforms are integrated into the laboratories of pharmaceutical, biotechnology, academia, government, and contract research organizations. With over 1,000 global associates – many possessing PhD-level expertise – we are proudly helping scientists propel discovery faster as described in over 230,000 peer-reviewed publications.

Customers: They’re at the heart of all we do
Our customers worldwide are setting the bar in numerous areas including: oncology, immunology, neurology, toxicology, vaccine, stem cell, food and beverage quality control, environmental, and biofuel research and testing. We’re dedicated to ensuring they go from data to insights as quickly and reliably as possible. We want to partner closely with you to create specific systems to address your biggest research challenges. We’re inspired to work with leading organizations on breakthroughs.
Innovation is in our DNA
In a race to develop medical treatment for the ailments of today—and those destined to emerge tomorrow—scientists must ensure their laboratories are modern and flexible enough to adapt as research needs change. This drives our research and development (R&D) team to continuously innovate and deploy cutting-edge, customizable, and automated solutions.
Surely every medicine is an innovation, and [they] that will not apply new remedies must expect new evils for time is the greatest innovator.
- Sir Francis Bacon
Our high-content imaging, high-throughput screening, genomic and cellular analysis, colony selection, and microplate detection systems are all designed with the latest technology to work seamlessly for researchers to help create better scientific workflows. Supporting our customers’ integrated workflows improves productivity, removing many of the assay roadblocks scientists often run into with a piecemeal laboratory setup.
Join our journey of scientific discovery
I couldn’t be more excited to pen this blog post and introduce this new e-platform to you. We’ll share trends our customers are setting in science and breakthroughs we’re enabling together with promises of a brighter, healthier future. Next up on the blog, we’ll highlight water immersion technology and its impact on high-content imaging , as well as introduce you to one of our field application scientists who discusses the latest trends in 3D cellular imaging.
We hope by sharing your insights it will inspire new discoveries and facilitate discussions that lead to even more advancements. Be part of our journey and let’s improve more lives, together.
To learn more about how Molecular Devices enables scientific discovery, visit https://www.moleculardevices.com/customer-breakthroughs.
Recent posts
Stem Cell Science and Regenerative Medicine – Technology and Methods Presented at ISSCR 2022
It was another great year at ISSCR 2022! Leaders from across the globe…
An automation journey for a high-throughput ELISA workflow
As your lab’s needs expand, automating every step of an intricate workflow…
How automated organoid cell cultures are developed, imaged, and analyzed
3D cell models are becoming increasingly popular for…
Synthetic Biology Automation: Five Tips to Improve Your Molecular Cloning Process
One of the biggest global concerns is our excessive use of resources and…
The role of Monoclonal Antibodies against COVID-19
Discover why mAbs are key in the fight against SARS-CoV-2 and how the…